Hongjie Xiong

Hongjie Xiong

Auto-generated profile, based on publicly available information

Hongjie Xiong

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P. R. China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
SCShundong Cai
Shundong Cai
JYJianhua Yan
Jianhua Yan
HXHongjie Xiong
Hongjie Xiong
YLYanfei Liu
Yanfei Liu
DPDongming Peng
Dongming Peng
Zhenbao LiuZhenbao Liu
Zhenbao Liu
Nucleic acid aptamers are single-stranded DNA or RNA of 20–100 nucleotides in length that have attracted substantial scientific interest due to their ability to specifically bind to target molecules via the formation of three-dimensional structures. Compared to traditional protein antibodies, aptamers have several advantages, such as their small size, high binding affinity, specificity, flexible structure, being chemical synthesizable and modifiable, good biocompatibility, high stability and low immunogenicity, which all contribute to their widely applications in the biomedical field. To date, much progress has been made in the study and applications of aptamers, however, detailed information on how aptamers bind to their targets is still scarce. Over the past few decades, many methods have been introduced to investigate the aptamer–target binding process, such as measuring the main kinetic or thermodynamic parameters, detecting the structural changes of the binding complexes, etc. Apart from traditional physicochemical methods, various types of molecular docking programs have been applied to simulate the aptamer–target interactions, while these simulations also have limitations. To facilitate the further research on the interactions, herein, we provide a brief review to illustrate the recent advances in the study of aptamer–target interactions. We summarize the binding targets of aptamers, such as small molecules, macromolecules, and even cells. Their binding constants (KD) are also summarized. Methods to probe the aptamer–target binding process, such as surface plasmon resonance (SPR), circular dichroism spectroscopy (CD), isothermal titration calorimetry (ITC), footprinting assay, truncation and mutation assay, nuclear magnetic resonance spectroscopy (NMR), X-ray crystallography and molecular docking simulation are indicated. The binding forces mediating the aptamer–target interactions, such as hydrogen bonding, electrostatic interaction, the hydrophobic effect, π–π stacking and van der Waals forces are summarized. The challenges and future perspectives are also discussed.

19 March 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
PDPeifang Du
Peifang Du
JYJianhua Yan
Jianhua Yan
SLShuo Long
Shuo Long
HXHongjie Xiong
Hongjie Xiong
NWNachuan Wen
Nachuan Wen
YLYanfei Liu
Yanfei Liu
A berberine 9-O-pyrazole alkyl derivative, a chemical compound (called B3) previously synthesized by our group, shows anti-cancer activity. However, B3 lacks targeting cytotoxicity to cancer cells, leading to obvious toxic side effects on normal cells. To solve this problem, here, we prepared a drug delivery system, namely, AS1411-GO/B3 for tumor targeting, in which nano-graphene oxide (GO) sheets were employed as the drug carrier, and the aptamer AS1411 was conjugated onto GO for tumor targeting. GO also had a photothermal effect, which helped the release of B3 from GO as well as the thermal cytotoxicity to cells. We found that the release of B3 could respond to acid conditions, indicating that the tumor intracellular environment could promote the release of B3, thus allowing it to perform chemotherapy effects. This system could also release B3 in response to photothermal heating, moreover, combined photothermal therapy and chemotherapy to improve the anticancer activity was achieved. This AS1411-GO/B3 platform with chemo-photothermal synergetic therapy provides a very promising treatment for tumors.

1 January 2019
Verified
Conference Paper
Closed access
HXHongjie Xiong
Hongjie Xiong
RRRaja Ramanthan
Raja Ramanthan
KNKhang Nguyen
Khang Nguyen